Mach7 Technologies Limited

ASX:M7T Stock Report

Market Cap: AU$78.4m

Mach7 Technologies Past Earnings Performance

Past criteria checks 0/6

Mach7 Technologies's earnings have been declining at an average annual rate of -3.9%, while the Healthcare Services industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 16.9% per year.

Key information

-3.9%

Earnings growth rate

7.3%

EPS growth rate

Healthcare Services Industry Growth42.6%
Revenue growth rate16.9%
Return on equity-15.4%
Net Margin-27.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Little Excitement Around Mach7 Technologies Limited's (ASX:M7T) Revenues As Shares Take 29% Pounding

Nov 06
Little Excitement Around Mach7 Technologies Limited's (ASX:M7T) Revenues As Shares Take 29% Pounding

Mach7 Technologies Limited (ASX:M7T) Just Reported And Analysts Have Been Cutting Their Estimates

Aug 30
Mach7 Technologies Limited (ASX:M7T) Just Reported And Analysts Have Been Cutting Their Estimates

Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues

Aug 01
Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Jan 29
Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business

Nov 23
Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business

Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?

Sep 29
Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?

Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)

Sep 04
Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)

Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching

Jun 13
Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Apr 28
We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Oct 24
An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Jun 23
Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

May 19
Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?

Nov 10
Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?

Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates

Jul 27
Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates

Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)

Feb 19
Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)

The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted

Jan 27
The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 46% Undervaluation?

Dec 06
Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 46% Undervaluation?

Revenue & Expenses Breakdown

How Mach7 Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:M7T Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2429-870
31 Mar 2428-770
31 Dec 2327-660
30 Sep 2329-360
30 Jun 2330-170
31 Mar 2329-260
31 Dec 2228-450
30 Sep 2227-450
30 Jun 2226-440
31 Mar 2226-340
31 Dec 2126-330
30 Sep 2123-630
30 Jun 2119-930
31 Mar 2118-930
31 Dec 2017-830
30 Sep 2018-430
30 Jun 2019030
31 Mar 2017-120
31 Dec 1915-220
30 Sep 1912-520
30 Jun 199-720
31 Mar 199-720
31 Dec 188-620
30 Sep 188-520
30 Jun 189-520
31 Mar 189-1130
31 Dec 179-1730
30 Sep 1710-1730
30 Jun 1710-1840
31 Mar 178-1630
31 Dec 166-1530
30 Sep 164-1430
30 Jun 162-1330
31 Dec 158-380
30 Jun 150-720
31 Dec 145-360
31 Dec 133-450

Quality Earnings: M7T is currently unprofitable.

Growing Profit Margin: M7T is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: M7T is unprofitable, and losses have increased over the past 5 years at a rate of 3.9% per year.

Accelerating Growth: Unable to compare M7T's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: M7T is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (19%).


Return on Equity

High ROE: M7T has a negative Return on Equity (-15.37%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 17:49
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mach7 Technologies Limited is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott PowerCGS International
ZheWei SimJefferies LLC
David LowJ.P. Morgan